Trademark Overview
On Friday, May 15, 2026, a trademark application was filed for PREGENE with the United States Patent and Trademark Office. The USPTO has given the PREGENE trademark a serial number of 99826741. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, May 15, 2026. This trademark is owned by Shenzhen Pregene Biopharma Co., Ltd.. The PREGENE trademark is filed in the Pharmaceutical Products category with the following description:
Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer and autoimmune diseases; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of autoimmune diseases; Stem cells for medical purposes; Immunoassay reagents for medical use; Cellular function activating agents for medical purposes; Pharmaceutical products for the treatment of cancer; Vaccines; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and...
